Novanta (NASDAQ:NOVT – Get Free Report) updated its FY 2026 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of 3.500-3.650 for the period, compared to the consensus estimate of 3.560. The company issued revenue guidance of $1.0 billion-$1.1 billion, compared to the consensus revenue estimate of $1.0 billion. Novanta also updated its Q2 2026 guidance to 0.810-0.860 EPS.
Analyst Ratings Changes
Several equities research analysts recently commented on the stock. Robert W. Baird raised shares of Novanta from a “neutral” rating to an “outperform” rating and cut their price objective for the company from $150.00 to $144.00 in a research report on Monday, March 30th. Zacks Research raised shares of Novanta from a “strong sell” rating to a “hold” rating in a research report on Friday, January 16th. Weiss Ratings reissued a “hold (c-)” rating on shares of Novanta in a research report on Friday, April 17th. Finally, Wall Street Zen cut shares of Novanta from a “buy” rating to a “hold” rating in a research report on Saturday, April 18th. One research analyst has rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, Novanta has a consensus rating of “Hold” and an average target price of $144.00.
View Our Latest Report on Novanta
Novanta Stock Up 1.2%
Novanta (NASDAQ:NOVT – Get Free Report) last issued its quarterly earnings results on Monday, May 11th. The technology company reported $0.81 EPS for the quarter, topping the consensus estimate of $0.77 by $0.04. Novanta had a net margin of 5.49% and a return on equity of 13.12%. The firm had revenue of $257.71 million for the quarter, compared to analysts’ expectations of $253.40 million. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q2 2026 guidance at 0.810-0.860 EPS. As a group, analysts expect that Novanta will post 3.54 EPS for the current fiscal year.
Insider Activity at Novanta
In other Novanta news, CEO Matthijs Glastra sold 6,500 shares of the company’s stock in a transaction that occurred on Friday, April 17th. The stock was sold at an average price of $130.05, for a total value of $845,325.00. Following the sale, the chief executive officer owned 56,761 shares in the company, valued at $7,381,768.05. This represents a 10.27% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Robert Buckley sold 9,957 shares of the company’s stock in a transaction that occurred on Monday, March 16th. The shares were sold at an average price of $116.77, for a total value of $1,162,678.89. Following the completion of the sale, the chief financial officer owned 96,616 shares in the company, valued at $11,281,850.32. This represents a 9.34% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 25,380 shares of company stock worth $3,296,276 in the last 90 days. Corporate insiders own 1.20% of the company’s stock.
Institutional Trading of Novanta
Institutional investors and hedge funds have recently bought and sold shares of the business. Danske Bank A S acquired a new position in Novanta in the 3rd quarter valued at about $40,000. Van ECK Associates Corp grew its stake in Novanta by 17.2% in the 3rd quarter. Van ECK Associates Corp now owns 1,627 shares of the technology company’s stock valued at $163,000 after buying an additional 239 shares during the last quarter. O Shaughnessy Asset Management LLC acquired a new position in Novanta in the 4th quarter valued at about $219,000. Boothbay Fund Management LLC acquired a new position in Novanta in the 3rd quarter valued at about $261,000. Finally, EntryPoint Capital LLC acquired a new position in Novanta in the 4th quarter valued at about $261,000. Institutional investors own 98.35% of the company’s stock.
Novanta Company Profile
Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.
Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.
Featured Articles
- Five stocks we like better than Novanta
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.
